Anacetrapib reduces (V)LDL cholesterol by inhibition of CETP activity and reduction of plasma PCSK9-Reference-Cited by-同舟云学术

Anacetrapib reduces (V)LDL cholesterol by inhibition of CETP activity and reduction of plasma PCSK9

Published:2015-11 Issue:11 Volume:56 Page:2085-2093
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

van der Tuin Sam J.L.,Kühnast Susan,Berbée Jimmy F.P.,Verschuren Lars,Pieterman Elsbet J.,Havekes Louis M.,van der Hoorn José W.A.,Rensen Patrick C.N.,Jukema J. Wouter,Princen Hans M.G.,Willems van Dijk Ko,Wang Yanan

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference54 articles.

1. Cholesterol Treatment Trialists' (CTT) Collaboration;Baigent;Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet.,2010

2. Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations;Davidson;Am. J. Cardiol.,2005

3. Major lipids, apolipoproteins, and risk of vascular disease;Di Angelantonio;J. Am. Med. Assoc.,2009

4. Plasma cholesteryl ester transfer protein;Tall;J. Lipid Res.,1993

5. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein;Marotti;Nature.,1993

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Density Lipoprotein Subfractions Remodeling: A Critical Process for the Treatment of Atherosclerotic Cardiovascular Diseases;Angiology;2023-02-14

2. Recent Update on the Development of PCSK9 Inhibitors for Hypercholesterolemia Treatment;Journal of Medicinal Chemistry;2022-11-29

3. A Novel, Orally Bioavailable, Small-Molecule Inhibitor of PCSK9 With Significant Cholesterol-Lowering Properties In Vivo;Journal of Lipid Research;2022-11

4. Dyslipidaemias and Cardiovascular Disease: Focus on the Role of PCSK9 Inhibitors;Current Medicinal Chemistry;2020-08-05

5. Therapeutic Potential of Quercetin as an Antiatherosclerotic Agent in Atherosclerotic Cardiovascular Disease: A Review;Evidence-Based Complementary and Alternative Medicine;2020-06-04